News / Media

Briotech Presents Prion Research at the US FDA

By special request of the US FDA, Briotech is invited to present its research supporting prion inactivation with use of BrioHOCl™.

UW Bothell Research Defining the Stability of BrioHOCl™

A barrel of Briotech’s HOCl could be shipped half way around the world and be ready to use years later, Williams said. In addition to its effectiveness against prions, the solution kills bacteria, ...

UW Bothell Presents Briotech at American Chemistry Society Conference

University of Washington, Bothell, presents Briotech's breakthrough in hypochlorous acid stability to the world’s largest scientific body in Washington, DC at the 254th American Chemistry Society C...